Navigation Links
Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
Date:9/2/2008

zophrenia. Depot formulations should be considered as a treatment option when a patient expresses a preference for such treatment due to convenience or if it is determined that a depot formulation is necessary to help avoid nonadherence to oral medications.(2)

Long-acting antipsychotic formulations have been associated with improved treatment adherence and reduced treatment failures.(3) By administering long- acting medications, healthcare professionals know when patients have received their medication and can immediately detect non-adherence when a patient fails to return for a scheduled injection.(4) Different from both oral and injected short-acting formulations, long-acting formulations of antipsychotics allow for stable concentrations of the active drug to remain at a therapeutic range for an extended period of time.(5)

About Schizophrenia

Schizophrenia is a severe and debilitating illness with symptoms such as delusions (false beliefs that cannot be corrected by reason), hallucinations (usually in the form of non-existent voices or visions), disorganized speech and severe disorganized or catatonic behavior. These signs and symptoms are associated with marked social or occupational dysfunction. Features of schizophrenia consist of characteristic signs and symptoms that have been present for a significant portion of time during a one-month period, with some signs of the disorder persisting for at least six months.(6) In addition to these symptoms, patients with schizophrenia are at greater risk for medical comorbidities than the general population.

About Olanzapine

Since olanzapine was introduced in 1996, it has been prescribed to approximately 24 million people worldwide. Olanzapine is not recommended for use in patients under 18 years of age.

In Europe, olanzapine is indicated for schizophrenia and in clinical trials, it has shown to be effective in maintaining the clinical improvement during continuation therapy in pa
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
2. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
3. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
4. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
5. New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients
6. New Survey Explores the Impact of Insulin Injections and Communications Between Patients and Healthcare Providers
7. BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
8. New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study
9. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
10. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
11. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/7qs3dw/corporate ... Reputation of Pharma in 2014 - a Perspective of ... their offering. This independent study, funded by ... with an interest in diabetes on the corporate reputation ... industry as a whole) in 2014. The results from ...
(Date:4/17/2015)... , April 17, 2015 Bionomics Limited (ASX:BNO, ... development of innovative therapeutics for the treatment of cancer ... the presentation of data from three of its most ... Cancer Research (AACR) 106 th Annual Meeting being ... PA USA. The presentation ...
(Date:4/16/2015)... 2015  Hologic, Inc. (NASDAQ: HOLX ) ... i published on-line this week in ... American Cancer Society. The study, by ... Center, supports current consensus guidelines ii for ... years of age be co-tested with both Pap ...
Breaking Medicine Technology:Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4
(Date:4/19/2015)... A live auction will be held to sell ... in Brooklyn, NY and other national consignors. Various types of ... exam and much more. , The auction will take ... 9:00am CDT each day. The equipment is at their Chicago ... 60160. Anyone can participate in the auction including those ...
(Date:4/19/2015)... 19, 2015 Family and friends of Brad ... in Memory of Brad Baddeley event to honor his ... , Bowling for Brains is cheduled to take place on ... Street in Lincoln, Nebraska. Participants may arrive at 12:30pm on ... , The cost is only $4 per game and 100% ...
(Date:4/18/2015)... April 19, 2015 The Residential ... during the past five years. The industry, which provides ... unable to fully care for themselves, has boomed on ... for dementia care for seniors with memory impairment. As ... an annualized rate of 4.1% to $1.9 billion over ...
(Date:4/18/2015)... Carinsurancesavings.biz has released a new blog ... cheaper during Spring. , Spring can be a ... should make sure they compare the newest policies before ... learn more about Spring car insurance offers by reading ... quotes are becoming more and more popular. Many insurance ...
(Date:4/18/2015)... "I wanted to live a healthier ... juice that contained essential vitamins, minerals and nutrients," ... my energy, improves skin elasticity and gives me ... Juice to contain fruits, vegetables and other healthful ... mental fatigue. It features a great taste. The ...
Breaking Medicine News(10 mins):Health News:Centurion to Sell Surplus Medical Equipment in Online and On-Site Auction 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Auto Insurance Plans Are Cheaper During Spring! 2
... drug called bivalirudin (Angiomax) that beats the standard combination ... as heart// attacks. This new blood thinner seems to ... syndromes. ,The Results of the ‘Acute Catheterization ... in November issue of the New England Journal of ...
... taking a widely used medication to strengthen fragile, aging ... a recent study led by Johns Hopkins// rheumatologist Clifton ... risedronate might be used to treat osteoarthritis after noticing ... class of drugs, not only slowed joint damage in ...
... More than ever, children and adolescents are enjoying ... organized sport. Yet many observers have noted problems ... medicine physicians have seen alarming increases in sport-related ... the Clinical Journal of Sport Medicine is a ...
... new vaccine that promises protection against a wide range of ... a cell-based technology in 11 weeks time.The vaccine is capable ... virus. ,It is still in the early phase of clinical ... detected in many countries. It has caused maximum damage in ...
... The global AIDS epidemic continues to spiral with 4.3 million ... for 65 percent of the cases, states a new UNAIDS ... Geneva Tuesday estimates that globally 39.5 million people are living ... including the 960,000 people who became newly infected in the ...
... grouped the five major cities Vancouver//, Calgary, Toronto, ... features namely income, education, recent immigrants, people living ... observes neighbourhoods and housing conditions and other social ... ,The amount of greenery around, safety of ...
Cached Medicine News:Health News:New Anti-Clotting Drug Less Risky For Heart Attack Patients 2Health News:Millions with Arthritis May Benefit from Bone Loss Drug 2Health News:Kids in Sport—Great for Fitness, but Concern About Injurie 2Health News:Kids in Sport—Great for Fitness, but Concern About Injurie 3Health News:More then Four Million New HIV Infections in 2006: UNAIDS 2Health News:Health Of Residents Is Affected by Various Factors 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: